SCHEMBL30950571

SCHEMBL30950571

CC(C)(C)OC(=O)NCc1ccc(-c2ccnc3nc(-c4ccccc4[N+](=O)[O-])[nH]c23)cc1F

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 20/20 0.59
▸ LCK P06239 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17664658 1.00 BTK (0.59) BTKLCK
SCHEMBL17645865 0.89 BTK (0.46) BTK
SCHEMBL17664656 0.88 BTK (0.62) BTKLCK
SCHEMBL30950545 0.87 BTK (0.53) BTKLCK
SCHEMBL17664721 0.87 BTK (0.53) BTKLCK
SCHEMBL30950546 0.82 BTK (0.56) BTKLCK
SCHEMBL17664722 0.82 BTK (0.56) BTKLCK
SCHEMBL17645685 0.76 BTK (0.42) BTK
SCHEMBL17645686 0.76 BTK (0.42) BTK
SCHEMBL17646025 0.76 BTK (0.42) BTKLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024129395-A1 BTK INHIBITORS GWYNANT THERAPEUTICS, INC. (US) 2024-06-20 — — WO disclosed
Send feedback